Home/DBV Technologies/Timothy E. Morris
TE

Timothy E. Morris

Board Member

DBV Technologies

Roles

Board MemberatDBV Technologies
Director; Chief Operating Officer of Humanetics CorporationatAquestive Therapeutics

DBV Technologies Pipeline

DrugIndicationPhase
VIASKIN® Peanut (DBV712)Peanut Allergy (Ages 1-3 years)Phase 3
VIASKIN® Milk (DBV135)Cow's Milk Protein Allergy (CMPA) (Ages 2-17)Phase 1/2
Multiple ProgramsAutoimmune & Inflammatory DisordersDiscovery/Pre-clinical